As product development and manufacturing costs in the pharmaceutical, medical device and technology industries increase often requiring substantial start-up capitalization and R&D investment, building successful joint ventures and strategic alliances can help recoup these expenses. But just as these sales and distribution partnerships represent opportunities to increase sales and expand market share, they can also be a source of hidden pitfalls. Our lawyers are experienced in creating and facilitating licensing, strategic alliance and joint venture transactions, and litigating the intellectual property and other issues arising upon the untimely termination of those relationships. The firm's corporate and intellectual property lawyers frequently join forces in a team effort not only driving the economics of the transaction, but also protecting the intellectual property that these alliances create and exploit.